The QualityStocks Daily Monday, February 10th, 2020

Today's Top 3 Investment Newsletters

QualityStocks (GLTC) +218.66%

Insider Financial (AEPT) +155.56%

StockMarketWatch (TCO) +53.22%

The QualityStocks Daily Stock List

American International Holdings Corp. (AMIH)

Street Insider, Market Screener, TipRanks, GuruFocus, Nasdaq, OTC Markets, Stocks to Buy, Wallet Investor, Last10k, Research Pool, Seeking Alpha, Wolf Street, Investors Hub, Trading View, MarketWatch, Stockopedia, Simply Wall St, Dividend Investor, GlobeNewswire and Ceo.ca reported previously on American International Holdings Corp. (AMIH), and today we report on the Company, here at the QualityStocks Daily Newsletter.

American International Holdings Corp. is a diversified holding company based in Houston, Texas. Its commitment is to acquiring, managing and operating health, wellness, beauty, and lifestyle companies, businesses and/or brands located in the U.S. and worldwide. American International looks for opportunities to acquire and grow businesses that have strong brand values and that can produce long-term sustainable free cash flow and attractive returns to maximize value for the Company and its stakeholders. Incorporated on August 18, 1986, American International Holdings lists on the OTC Markets.

The Company has its subsidiary, YS Brands, Inc. YS Brands was created as a wholly-owned subsidiary. Its commitment is to creating, designing, manufacturing and marketing new premium designer shoe concepts intended to sell through direct to consumer (retail and e-commerce) and wholesale by way of larger, bigger box retail stores.

Also, American International Holdings owns and operates a medical spa under the Novopelle brand name in McKinney, Texas. In October 2019, the Company announced that it appointed Mr. JJ Dickens, as the Chief Executive Officer (CEO) of its newly established wholly-owned subsidiary, Capitol City Solutions USA, Inc. (CCS). CCS was created to act as a general contracting and construction company focused on the remodeling, general construction and interior finish of the Company’s newly formed Novopelle branded med spa locations and also to market to other commercial real estate projects within the United States. Mr. Dickens brings more than 10 years of construction and project management experience to CCS.

This past December, American International Holdings announced that its wholly-owned subsidiary, Novopelle Diamond, LLC, was in the process of expanding its present product and service offerings to include additional regenerative, anti-aging, weight management, and overall health and wellness services. This is to meet the needs of its existing and future clientele.

Last month, American International Holdings announced that its wholly-owned subsidiary, Capitol City Solutions USA, Inc. (CCS), executed a construction contract with a multi-family apartment investment and management company. This is to provide water mitigation, demolition, interior finish out and remodeling, and flooring repairs for a multi-family apartment complex in Beaumont, Texas. The construction contract has a value of more than $6,690,000, subject to adjustment and subject to draws being made under the agreement, over time, and subject to completion of demolition and construction services milestones.

In addition, last month, American International Holdings announced that its newly formed subsidiary, Novopelle Tyler, Inc. (Novopelle Tyler), entered into a Lease Agreement with Asher Park, LLC. This is to lease and occupy about 1,900 square feet of commercial retail space located in Tyler, Texas with the plan to open and operate a Novopelle Med Spa at the location.

Mr. Jacob Cohen, American International Holdings’ Chief Executive Officer, said, “We are very excited to announce the entry into this lease agreement to provide for a location for what will become our newest Novopelle branded medical spa, which we strategically chose to be located at the entrance of the affluent Hollytree subdivision in Tyler, Texas.”

American International Holdings Corp. (AMIH), closed Monday's trading session at $0.32, even for the day, on 4,960 volume with 7 trades. The average volume for the last 3 months is 30,059 and the stock's 52-week low/high is $0.184/$0.665600001.

chart

Balmoral Resources Ltd. (BALMF)

Streetwise Reports, Proactive Investors, OTC Markets, Mining.com, GlobeNewswire, Northern Miner, Metals News, ABN Newswire, Equedia, Investing.com, Mining Feeds, InvestorsHub, Mining Atlas, Junior Mining Network, News Scanner, Dividend Investor, Resource World, Stockhouse, Trading View, Investing News, and Wallet Investor reported previously on Balmoral Resources Ltd. (BALMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Balmoral Resources Ltd. is an exploration company exploring a portfolio of gold and base metal properties situated within the prolific Abitibi greenstone belt. Its flagship, 1,000 km2 Detour Gold Trend Project hosts the resource-stage Bug and Martiniere West gold deposits and the Grasset nickel-copper-cobalt-PGE deposit. Balmoral is led by an experienced and successful Board of Directors and Management team with a lengthy track record of creating shareholder value via the exploration process. OTCQX-listed, Balmoral Resources is based in Vancouver, British Columbia.

The Company has dual exposure to the gold and nickel sulphide markets. Its gold projects comprise Martiniere, Northshore, N2, Lynx-Rambo, Lac Du Doight, Grasset Gold, Area 52 (Fenelon), Detour Trend, and Vortex Ext. Balmoral’s nickel projects comprise Grasset, GUC Central, Gargoyle, RUM, Goblin, as well as Ghost.

Grasset is a Nickel-Copper-Cobalt- PGE Deposit. It is the most advanced of the nickel discoveries made by Balmoral Resources in the Grasset Ultramafic Complex. The Project is 100 percent owned by Balmoral - royalty free. 2018 drilling extended the H1 Zone of the deposit to 800 vertical meters (an increase of more than 300 meters) and planned winter 2020 drilling is targeting the H3 Zone to a similar depth.

The Grasset Nickel Deposit features some of the highest tenor (nickel content) sulphides in Canada. This allows it to produce very high nickel grades. Balmoral previously announced additional discoveries within the Grasset Ultramafic Complex 7 km to the NW. At the Grasset Nickel Deposit, nickel, copper, cobalt, platinum and palladium are all considered recoverable and payable.

Recently, Balmoral Resources announced it was named to, and ranked 12th on the 2020 OTCQX® Best 50. This is a ranking of top performing companies that traded on the OTCQX Best Market in 2019. This marks the third time in the past six years that Balmoral Resources has been included on this annual Best 50 list. In addition, the Company was recently recognized as one of the top 3 best performing B.C.-based mining stocks on the Toronto Stock Exchange in 2019 by Business in Vancouver magazine.

Last week, Mr. Eric Sprott announced that, 2176423 Ontario Ltd., a corporation that is beneficially owned by him, acquired ownership of 1,000,000 common shares of Balmoral Resources Ltd. over the Toronto Stock Exchange (representing about 0.56 percent of the outstanding shares on a non-diluted basis) at $0.47 per share for aggregate consideration of roughly $466,000.

Mr. Sprott now beneficially owns and controls 16,130,353 shares and 2,941,176 warrants (representing approximately 9.1 percent on a non-diluted basis and 10.54 percent on a partially diluted basis assuming exercise of such warrants).

Balmoral Resources Ltd. (BALMF), closed Monday's trading session at $0.34, off by 2.8571%, on 199,820 volume with 49 trades. The average volume for the last 3 months is 259,644 and the stock's 52-week low/high is $0.000799999/$0.07.

chart

Blueharbor Bank (BLHK)

OTC Markets, TipRanks, Stockscores, MarketScreener, Barchart, Stockopedia, GuruFocus, Stockhouse, Wallet Investor, Simply Wall St, Seeking Alpha, dividata, TradingView, YCharts, Morningstar, Dividend Investor, Investors Hangout, and Nasdaq reported earlier on Blueharbor Bank (BLHK), and today we also highlight the Company, here at the QualityStocks Daily Newsletter.

Established in 2008, blueharbor bank provides diverse banking products and services. It serves Iredell County, northern Mecklenburg County, and surrounding areas via its banking offices in Mooresville, Statesville, and Huntersville, North Carolina. blueharbor bank lists on the OTC Markets. The Company has its corporate headquarters in Mooresville, North Carolina.

blueharbor bank offers its Neon Blue checking account. Its Neon Blue checking account seems like one’s average checking account. However, they get a very good interest rate just for using direct deposit, online bill pay, e-statements and their debit card. In addition, there's no minimum balance and no monthly maintenance fee.

On the whole, blueharbor bank accepts personal and business checking, savings, and investment accounts. Furthermore, it offers personal loans and business loans. Moreover, the Company provides credit cards; and remote deposit capture and merchant services.

Mr. Jim Marshall is President & Chief Executive Officer of blueharbor bank. He is a graduate of Campbell University where he received a Bachelor of Science in Business and a certification in Trust Management. Mr. Marshall is also a graduate of the Louisiana State University School of Banking. His whole banking career has been in North Carolina where he started with First Citizens Bank based in Raleigh.

Mr. Don Flowe is Senior Vice President & Chief Credit Officer of blueharbor bank. He is a graduate of the University of North Carolina at Charlotte where he earned a Bachelor of Arts degree in Business Administration. In addition, Mr. Flowe is a graduate of Duke University where he earned a Masters in Business Administration. He has served in numerous roles in regional and community banks. This includes Chief Risk Officer, Commercial Banking Group Manager and Area Executive.

On February 3, 2020, blueharbor bank reported Net Income of $888,835 and $0.29 per diluted share for Q4 of 2019. This represents an increase of 72 percent or $371,153 versus $517,682 and $0.17 per diluted share for Q4 of 2018. The increase in Net Income is because of an increase in Interest Income of $433,941, slightly offset by an increase in Interest Expense of $128,803.

Average Interest Earning Assets for the quarter ended December 31, 2019, were $220.1 million. This represents an increase of $26.1 million over the Average Interest Earning Assets for the quarter ended December 31, 2018, of $194.0 million. This increase included an increase in the Average Commercial Loans of $22.3 million. The Yield on Interest Earning Assets also increased 23 basis points from 4.66 percent for the quarter ended December 31, 2018, to 4.89 percent for the quarter ended December 31, 2019.

Blueharbor Bank (BLHK), closed Monday's trading session at $12.70, even for the day, on 80 volume with 1 trade. The average volume for the last 3 months is 626 and the stock's 52-week low/high is $0.026799999/$0.127149999.

chart

Fuling Global, Inc. (FORK)

Zacks, Weeklywall, Stocktwits, ShareInvestor, MarketWatch, MacroTrends, StockInvest.us, Market Chameleon, Infront Analytics, Equities, Nasdaq, Street Insider, PR Newswire, Super Stock Screener, Seeking Alpha, Investing.com, Morningstar, MarketBeat, and Simply Wall St reported beforehand on Fuling Global, Inc. (FORK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Fuling Global, Inc. manufactures and distributes plastic and paper serviceware for the foodservice industry. It has precision manufacturing facilities in the USA, Mexico and China. Fuling Global sells its products directly, and also via distributors to dealers, QSRs (Quick Service Restaurants), manufacturers, and retailers. Formed in 2015, Fuling Global has its head office in Wenling, the People's Republic of China (PRC). The Company’s shares trade on the NasdaqCM.

Fuling Global’s plastic and paper serviceware products include disposable cutlery, drinking straws, cups, plates and other plastic and paper products. These products are used by greater than 100 customers primarily from the U.S., China and Europe. These customers include Subway, Wendy's, Burger King, Taco Bell, KFC (China only), Walmart, and McKesson.

Currently, Fuling Global has four factories in China and one in the U.S. with more than 1,500 employees. The yearly production capacity is around 50,000 tons including GPPS,PS,PP,PLA,PET.

Last month, Fuling Global announced that Ms. Peng (Gillian) Hu was named Chief Financial Officer (CFO). Ms. Hu succeeds Ms. Meihong Pan, who has served as interim CFO since November of 2019. Ms. Pan will remain with Fuling Global as its Financial Controller, a position she has held since 2006. Before joining Fuling Global, Ms. Hu was the Financial Controller at Hunan International Economics University, a subsidiary of Nasdaq-listed Laureate Education, Inc. She previously held auditor positions at Friedman LLP and Ernst & Young. Fuling Global's previous CFO, Gilbert Lee, presently serves as a consultant to Fuling Global, centered on international expansion programs.

Xinfu Hu, Chief Executive Officer of Fuling Global, said in January, "A highly experienced and skilled financial executive, Gillian has significant Chinese GAAP and US GAAP accounting experience, and we are excited that she is joining Fuling Global at an important juncture in our evolution. Gillian will play a key role as we focus on growth initiatives, including international expansion and the introduction of new, environmentally friendly products to foodservice customers around the world."

Fuling Global, Inc. (FORK), closed Monday's trading session at $2.2077, off by 1.00%, on 7,559 volume with 44 trades. The average volume for the last 3 months is 3,139 and the stock's 52-week low/high is $0.27000001/$1.50.

chart

North American Cannabis Holdings, Inc. (USMJ)

SmallCap Exclusive, Investor Ideas, Micro Small Cap, hot Stocked, Real Investment Advice, Tech Stock Observer, Pitchbook, Research Pool, Nasdaq, Stockhouse, Morningstar, Market Exclusive, Daily Marijuana Observer, Insider Financial, Seeking Alpha, BioSpace, Wallet Investor, InvestorsHub, GlobeNewswire, PR Newswire, Simply Wall St, Dividend Investor, GuruFocus, and Wolf Street reported beforehand on North American Cannabis Holdings, Inc. (USMJ), and today we report on the Company, here at the QualityStocks Daily Newsletter.

North American Cannabis Holdings, Inc., via its subsidiaries, operates in the legal cannabis market in the United States. It conducts various pilots in the legal cannabis sector so as to explore different high growth potential business opportunities. The Company formerly went by the name Algae International Group, Inc. It changed its name to North American Cannabis Holdings, Inc. in June of 2015. Based in Texas, the Company’s shares trade on the OTC Markets.

North American Cannabis also operates a destination beverage company. It enables consumers to interface with staff to learn about the specific benefits of cannabis, and select healthy and refreshing cannabis infused beverages, which include custom blended hemp infused coffee, cold pressed juices, as well as smoothies. In addition, it offers raw hemp seeds and other hemp infused foods.

The Company has a curated product line of legal cannabinoids and accessories. All of North American Cannabis’ products are lab-tested and contain no THC (tetrahydrocannabinol) through a carefully monitored extraction process. Its products are all natural, all safe, and also all CBD (cannabidiol).

This past December, North American Cannabis Holdings, Inc. (USMJ) announced adding the Urban CBD Collective Topical Set to its increasing array of CBD products available for sale on its eCommerce site www.USMJ.com. The Urban CBD Collective Topical Set comes with two CBD balms. One is for under eye puffiness and dark circle's and the other one is for sore muscles.

Last month, North American Cannabis Holdings (USMJ) announced that its eCommerce site, www.USMJ.com, now has greater than 150 CBD, Hemp, and Cannabis Essentials. Company Management reported the number of daily visitors to the www.USMJ.com eCommerce site is growing significantly. This site was launched in 2019 featuring EVERx CBD Sports Water from USMJ's partner Puration, Inc. (USOTC: PURA). Among other products, USMJ added Hemp4mula Chewing Gum and Hemp4mula Gummies, CBD infused candies from Kali-Extracts (USOTC: KALY). In January 2020, USMJ featured HEMPZ moisturizer.

Moreover, in January, North American Cannabis Holdings (USMJ) announced CBD and CBG Smokables in Pre Roll and Flower are now available on its eCommerce site www.USMJ.com. USMJ carries manifold CBD and CBG Smokable products in Pre Roll and Flower.

North American Cannabis Holdings, Inc. (USMJ), closed Monday's trading session at $0.0003, even for the day, on 11,924,254 volume with 40 trades. The average volume for the last 3 months is 54,522,193 and the stock's 52-week low/high is $0.14/$0.212999999.

chart

SpeakEasy Cannabis Club Ltd. (SPBBF)

Midas Letter, OTC.Watch, 4-Traders, Seeking Alpha, Stockhouse, Wallet Investor, Nasdaq, Pot Network, Morningstar, Simply Wall St, InvestorsHub, Stockwatch, TradingView, Dividend Investor, and GuruFocus reported earlier on SpeakEasy Cannabis Club Ltd. (SPBBF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

SpeakEasy Cannabis Club Ltd. concentrates on producing medical cannabis in Canada. It owns roughly 290 acres of land in Rock Creek, British Columbia. SpeakEasy represents a collective of the leading cannabis growers in Canada, sharing decades of knowledge and experience to produce first-class product. Fundamentally, SpeakEasy is an incubator designed to support industry-leading talent with the shared knowledge, resources, and passion of its entire operation. The Company lists on the OTC Markets. SpeakEasy Cannabis Club has its corporate office in Vancouver, British Columbia.

The Company’s 290-acre facility is in the South Okanagan Valley. SpeakEasy is the only licensed producer applicant in British Columbia’s renowned ‘Golden Mile’. The Company’s innovative business model enables each grower to operate independently. It also gives them the freedom to develop each strain to perfection.

Mr. Marc Geen is Founding Chief Executive Officer (CEO) & Adviser to the Board of Directors. He is a 4th-generation British Columbia farmer. Mr. Geen has been active in the legal medical marijuana industry for over a decade, consulting, complying with, and participating in the MMAR, MMPR, and ACMPR programs. Before co-founding Speakeasy Cannabis Club Ltd., he spent 14 years as Head of Operations for Kettle Mountain Ginseng Ltd.

Dr. Bin Huang is CEO & Director of SpeakEasy Cannabis Club. Dr. Huang joined the Company in June 2019 as CEO. She is an experienced life-sciences executive with experience in strategy and new business development, financing and public markets, corporate governance, and operations management in North America and Asia. Dr. Huang’s work experience includes 18 years as CEO of life-sciences companies, most recently CEO of Emerald Health Therapeutics, Inc.

In January, SpeakEasy Cannabis Club announced that it signed a non-binding Letter of Intent (LOI) with M&J Orchards Ltd. to plant 50 acres of hemp in 2020 on M&J’s property. SpeakEasy’s property has already undergone stringent approval processes from the Agricultural Land Reserve, Federal, Provincial, Municipal governments and Health Canada for the cultivation of THC (Tetrahydrocannabinol) bearing cannabis. SpeakEasy finds it necessary to lease land so it can grow industrial hemp and secure a supply of CBD (cannabidiol) bearing hemp that would meet its biomass standards.

The expectation is that demand for CBD will be more than the Company could possibly grow on its land package. Thus, strategic partnerships with land owners and operators to produce industrial hemp is vital for SpeakEasy to keep up with demand. Throughout the 2020 season, it will continue to develop its Phase 2 outdoor grow facility on the remaining land suitable for growing cannabis on its 290 acre property. The Company expects it to be licenced and ready for the 2021 grow season.

Last week, SpeakEasy Cannabis Club announced the appointment of Mr. Bill Fleming, an independent Director, to its Board of Directors at its 2020 Annual General Meeting. Mr. Fleming has founded and served as CEO for several entrepreneurial companies. He has served with senior executive teams dealing with equity and debt financings. Mr. Fleming has developed corporate strategies for a broad array of companies, from family-owned businesses to multi-national companies. At present, Mr. Fleming serves as President of Mernova Medicinal, Inc., which recently sold to Switzerland based Creso Pharma Limited.

SpeakEasy Cannabis Club Ltd. (SPBBF), closed Monday's trading session at $0.2896, even for the day, on 500 volume. The average volume for the last 3 months is 7,583 and the stock's 52-week low/high is $0.0103/$0.037500001.

chart

Tonogold Resources, Inc. (TNGL)

OTC Markets, Emerging Growth, OTC Dynamics, Proactive Investors, OTC.Watch, YCharts, Stockopedia, Seeking Alpha, Market Screener, 24hgold, PR Newswire, Nasdaq, TMXmoney, Simply Wall St, GlobeNewswire, wallstreet:online, travelwirenews, Barchart, InvestorsHub, Agoracom, Trading View, Investors Hangout, Mexico Mining Center, GuruFocus, Cambridge House International, RedCloudfs.com, The Prospector News, Junior Mining Network, Ceo.ca, TipRanks, Equities.com, Morningstar, Wallet Investor, and MarketWatch reported previously on Tonogold Resources, Inc. (TNGL), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Tonogold Resources, Inc. operates as a resource/mining company with gold and silver properties in Mexico and the USA. It chiefly concentrates on assessing options over the Comstock and Mexican gold/silver properties. Incorporated in 1997, Tonogold Resources has its corporate office in La Jolla, California. A leading junior mining company, Tonogold lists on the OTC Markets.

In addition, the Company owns a 100 percent interest in the NevMex iron ore project in Sonora, Mexico. On October 5, 2017, Tonogold Resources announced that it entered into a binding agreement with Comstock Mining, Inc. (NYSE American: LODE) that among other things, provides Tonogold an exclusive right to earn a 51 percent controlling interest in 1,162 acres of mining claims in the highly prospective Comstock Lode region in Virginia City, Nevada, which includes the Lucerne Deposit, situated in the Storey and Lyon Counties.

In June 2019, Comstock Mining announced that Tonogold Resources paid an additional non-refundable cash deposit of $600,000 toward the purchase of Comstock’s Lucerne properties. On January 24, 2019, Comstock Mining entered into an agreement with Tonogold Resources to sell its Lucerne properties for $15 million ($11.5 million in cash and $3.5 million in stock).

On June 21, 2019 Comstock Mining entered into a Third Purchase Agreement Amendment. It provided for Tonogold Resources to deliver $11.5 million in cash at closing, less the total amounts of the cumulative non-refundable cash payments made by Tonogold at that time, now totaling $2.95 million as of June 27, 2019.

This past November, Tonogold Resources announced the Closing of the Comstock acquisition with Comstock Mining. Earlier in 2019, Tonogold Resources and Comstock Mining entered into that agreement wherein Tonogold would acquire a 100 percent interest in the Lucerne project; an exclusive 20-year lease to use, operate, and manage Comstock’s processing facilities, plant, infrastructure and mining claims (known as the American Flats Properties); and 100 percent rights to explore, develop, and mine Comstock’s Storey County claims, including those covering the significant historic production at Gold Hill and Virginia City (Storey Exploration Claims) for total consideration of $15 million. The Completion of the Storey Exploration Claims took place in September of 2019.

Tonogold Resources, Inc. (TNGL), closed Monday's trading session at $0.53, up 6.2124%, on 27,544 volume with 14 trades. The average volume for the last 3 months is 14,986 and the stock's 52-week low/high is $1.14999997/$5.82000017.

chart

TOMI Environmental Solutions, Inc. (TOMZ)

Infront Analytics, TeleTrader, Morningstar, Simply Wall St, GuruFocus, Wallmine, Stockopedia, InvestorsHub, Capital Cube, Last10k, Wallet Investor, Stockhouse, 4-Traders, GlobeNewswire, Seeking Alpha, and Market Screener reported on TOMI Environmental Solutions, Inc. (TOMZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

TOMI Environmental Solutions, Inc. is an international company headquartered in Beverly Hills, California. It specializes in disinfection and decontamination employing its premier Binary Ionization Technology® (BIT™) platform via the manufacturing, licensing, servicing, and selling of its SteraMist® brand of products - a hydrogen peroxide-based mist and fog. The four principal divisions of TOMI include Hospital-Healthcare, Life Sciences, TOMI Service Network (TSN), and Food Safety. The Company lists on the OTC Markets Group’s OTCQB.

The design of TOMI products are to service a wide array of commercial structures. In addition, the Company’s products and services have been used in single-family homes and multi-unit residences. TOMI Environmental Solutions develops training programs and application protocols for its clients. TOMI is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, and The Restoration Industry Association.

TOMI’s BIT™ solution uses a low percentage Hydrogen Peroxide as its only active ingredient to produce a hydroxyl radical (.OH ion), referred to as ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol. This aerosol works like a visual non-caustic gas. SteraMist is an EPA (Environmental Protection Agency) registered sole active ingredient Hydrogen Peroxide based product line.

In 2015, TOMI Environmental Solutions received its first EPA hospital-healthcare general disinfectant label, in what is regarded as a heavily regulated and very competitive industry. In 2016, the Company amended the label to include C.difficle spores and h1n1. In 2017, the EPA approved additional registrations of Salmonella and Norovirus to the TOMI label. Additionally, Binary Ionization Technology (BIT) can be found on EPA Lists K, L, G, and M.

Recently, TOMI Environmental Solutions announced that it manufactured, installed, and validated a SteraMist® iHP™ Plasma Decontamination Chamber, a new Company product offering, at the University of Houston. The University of Houston will use its newly designed iHP Plasma Decontamination Chamber weekly to at the same time disinfect up to 300 rodent cages in three hours. TOMI programmed the system with pre-set programs that will permit versatility in disinfecting other lab equipment as required.

TOMI Environmental Solutions will hold its Q2 2019 financial results conference call on Monday, August 26th at 1:30 p.m. PT, 4:30 p.m. ET.

TOMI Environmental Solutions, Inc. (TOMZ), closed Monday's trading session at $0.32, up 43.1767%, on 895,262 volume with 168 trades. The average volume for the last 3 months is 143,965 and the stock's 52-week low/high is $0.024599999/$0.121299996.

chart

Greene Concepts, Inc. (INKW)

All Cap Research, Street Insider, OTC Dynamics, The WS News Publisher, Investing.com, Simply Wall St, WeTradeHQ, Otc.watch, Stockwatch, Stockopedia, Investingonline.com, Seeking Alpha, TradingView, otcprwire, Dividend Investor, Morningstar, OTC Markets, Wallet Investor, Stockhouse, Globe Newswire, and InvestorsHub reported earlier on Greene Concepts, Inc. (INKW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Greene Concepts, Inc. is an emerging leader in the worldwide scientifically formulated beverage industry. Via its recently acquired wholly-owned subsidiary, Mammoth Ventures, Inc., the Company has entered into the specialty beverage and bottling business. Greene Concepts lists on the OTC Markets. The Company is headquartered in Clovis, California.

Greene Concepts entered into a definitive agreement on December 28, 2018 to purchase a bottling and beverage facility. This includes land and equipment. The facility will focus on an array of beverage product lines including, but not limited to, CBD (cannabidiol) infused beverages, spring and artesian water, and enhanced athletic drinks in addition to other product offerings.

Greene Concepts has completed the 100 percent acquisition of Mammoth Ventures, Inc., a holding company. The acquisition includes the 60,000 sq. ft. beverage and bottling facility located just outside of Asheville, North Carolina.

This past June, Greene Concepts announced that it expects a near term operations relaunch with pilot production runs debuting high margin specialty and enhanced beverages targeted for the $93.68 billion worldwide functional drinks market. In preparation for an operations relaunch at the plant, a 30-plus year veteran of the bottling industry was appointed plant manager to supervise all renovations.

Recently, Greene Concepts updated shareholders that water purity standards far surpassing industry norms have been implemented at its bottling facility in Marion, North Carolina. The worldwide bottled water industry is forecast to reach $215.12 billion by 2025, according to Grand View Research, Inc. Beverage Marketing corporation projects within the next few years, individual consumers will drink greater than 50 gallons of bottled water annually.

Karen Howard, Chief Executive Officer of Greene Concepts, said, “As our bottling facility approaches relaunch, we are committed to bottling the cleanest water possible, and test to the highest standard for arsenic of no more than .005 mg/liter, the equivalent of 5ppb. The FDA standard is 10ppb.”

Greene Concepts, Inc. (INKW), closed Monday's trading session at $0.00285, up 35.7143%, on 5,966,078 volume with 27 trades. The average volume for the last 3 months is 3,896,340 and the stock's 52-week low/high is $0.003599999/$0.05.

chart

West Coast Ventures Group Corp. (WCVC)

All Penny Stocks, TipRanks, Market Screener, Market Wire News, Last10k, Wallet Investor, TradingView, Simply Wall St, InvestorsHub, Stockwatch, Stockhouse, GlobeNewswire, 4-Traders, and PR Newswire reported previously on West Coast Ventures Group Corp. (WCVC), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

West Coast Ventures Group Corp. is America's first CBD restaurant stock under “Illegal Brands”. The Company operates several contemporary restaurant concepts. This includes the flagship Illegal Burger, a quick-casual burger + bar concept. West Coast Ventures’ shares trade on the OTC Markets Group’s OTCQB. The Company has its head office in Denver, Colorado.

West Coast Ventures’ team includes extensive restaurant management experience, business experts from numerous industries, marketing experts and investment experts. Mr. Jim Nixon is the Chief Executive Officer of West Coast Ventures Group Corp. The Company’s holdings include the above-mentioned chain Illegal Burger that Mr. Nixon founded in 2013. Mr. Nixon brings greater than three decades of progressively responsible experience in every aspect of the restaurant business.

Recently, West Coast Ventures Group announced the continued success of its Illegal Brands concepts. The Company has launched its latest restaurant, Illegal Pizza. The first Illegal Pizza restaurant opened in Lauderdale, Florida on June 13, 2019. Illegal Pizza takes what made Illegal Burger popular and refines the concept with build your own pizzas and wide-ranging options for an array of dietary requirements. In addition, the location sells Illegal Brands CBD water and sachets.

The expectation is that this location will bring in approximately $700,000 within the first year. It will be the first of many Illegal Pizza locations across the nation.

West Coast Ventures Group also recently announced that its Illegal Brands CBD offerings continue to grow in popularity and diversity. Two of the Company’s flagship Illegal Burger franchises have already experienced significant success. The IB CitiSet is on pace to surpass $700,000 in sales in its first full year of operations. The IB Writer Square in Downtown Denver is also on pace to surpass $1 million in sales in 2019. West Coast Ventures has turned Illegal Burger into a full fledged franchise offering.

West Coast Ventures Group Corp. (WCVC), closed Monday's trading session at $0.0002, up 100.00%, on 46,676,875 volume with 20 trades. The average volume for the last 3 months is 77,104,797 and the stock's 52-week low/high is $0.949999988/$4.00.

chart

Anvia Holdings Corporation (ANVV)

Stock Target Advisor, GlobeNewswire, MarketWatch, Barchart, Simply Wall St, GuruFocus, Stockhouse, Trading View, Market Screener, Last10k, Stockwatch, Wallet Investor, Dividend Investor, and InvestorsHub reported beforehand on Anvia Holdings Corporation (ANVV), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Anvia Holdings Corporation is an international technology for self and business improvement company. It has acquired and developed a number of proprietary software, mobile applications, learning and educational tools to help consumers and businesses improve and grow. The Company’s mission is to make personal and business growth accessible and sustainable.

The Company was previously known as Dove Street Acquisition Corporation. It changed its name to Anvia Holdings Corporation in January of 2017. Founded in 2016, Anvia Holdings is headquartered in Glendale, California.

The Anvia business and organizational portfolio comprises software and mobile application technologies, consulting services, coaching services, and blended learning content and activities. Some of the areas it serves its business clients are Strategy Management, Competency Management, Performance Management, Learning Management, Customer Experience Management, Franchise, Corporate Advisory and Listing, and HR Information Systems.

Recently, Anvia Holdings announced that it executed a definitive agreement to acquire all of the issued and outstanding shares of XSEED Pty Ltd, an Australian Registered Training Organization. With this agreement, Anvia Holdings, via its fully-owned subsidiary Anvia (Australia) Pty Ltd shall acquire 100 percent of XSEED Pty Ltd outstanding shares for approximately USD 352,000 (AUD 500,000). XSEED engages in the provision of vocational education training (VET) and offers courses that are for the Automotive and Hairdressing industries.

Anvia (Australia) Pty Ltd Chief Executive Officer, Mr. James Kennett, said “Adding XSEED to our education services portfolio solidifies our position in Australia as a major player in Education Services. In addition, XSEED will diversify our current CRICOS and Corporate learning income with further revenue sources.”

Also recently, Anvia Holdings announced it filed an application to list its common shares on the NASDAQ Capital Market. Ali Kasa, Chief Executive Officer and President of Anvia Holdings, said, “The listing of our common shares on NASDAQ would reflect the progress we are making to strengthening our corporate governance and mark another significant milestone in our quest to become a global leader in the self and business improvement industry.”

Anvia Holdings Corporation (ANVV), closed Monday's trading session at $0.005, up 354.5454%, on 7,243 volume with 1 trade. The stock's 52-week low/high is $0.005501/$0.039599999.

chart

Petrogress, Inc. (PGAS)

NetworkNewsWire, Marketbeat, Last10k, MarketWatch, Whale Wisdom, OilandGas360, Trading View, Investors Hangout, Stockhouse, Stockwatch, StockInvest, Barchart, 4-Traders, YCharts, Wallet Investor, Simply Wall St, GuruFocus, Stockopedia, and Dividend Investor reported earlier on Petrogress, Inc. (PGAS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Petrogress, Inc., by way of its subsidiaries, operates as an integrated merchant of petroleum products. The Company is an independent Oil energy and Shipping company. It specializes in oil exploration, production, trade and sea transportation with global operations throughout Europe, Africa and the Middle East. The Company owns and operates a fleet of tankers from its base in the historic Port of Piraeus through a series of Marshall Islands subsidiaries. Petrogress is based in Delaware and New York and lists on the OTC Markets.

The Company operates mainly as a holding company for its wholly-owned subsidiaries. Petrogress concentrates on the supply and trade of light petroleum fuel oil, refined oil products and other petrochemical products to local refineries in West Africa and Mediterranean countries.

In addition, Petrogress operates service and shipping facilities at the Port of Limassol in Cyprus and the Port of Tema, Greater Accra, in Ghana. The Company is actively looking for expansion opportunities. This includes in operating and developing natural gas production and transmission facilities along with LNG processing in the United States, refinery operations in north and West Africa, and the transport and sales of LNG in Europe.

For Upstream - oil resources and exploration, Petrogress has its Petrogres Oil & Gas Energy, Inc. subsidiary. For Midstream - product fleet carriers, the Company has its Petronav Carries, LLC subsidiary. Regarding Downstream – processing and refining, it has its J/V PGO & PGL – Ghana subsidiary. Furthermore, regarding Marketing – purchases and sales, Petrogress has its Petrogres Co. Limited subsidiary.

In December of 2018, Petrogress announced that its Petrogress Int’l, LLC (PIL) subsidiary entered into a Partnership Agreement with Deliman Oil Company Limited, a Ghanaian corporation. This Agreement is to jointly create and co-operate a Ghanaian corporation to be called PG&D Fueling. PG&D will operate and manage gas/refueling stations in Ghana, Burkina Faso and Niger and associated storage and distribution operations.

The expectation is that PG&D will initially operate and manage 65 gas stations now owned by Deliman in Ghana and Burkina Faso. The petrochemical products to be distributed via PG&D managed gas stations will be supplied by PIL affiliate company Petrogres Co. Limited, via its partnership with Platon Oil Refinery in Ghana.

Recently, Petrogress announced that its PIL subsidiary entered into an Exclusive Distribution Agreement with Dana Lubricants Factory LLC (Dana Lubes), a United Arab Emirates (UAE) based lubricant oil manufacturer. This agreement designates PIL as the exclusive agent for distribution of products manufactured and branded by Dana Lubes throughout western Africa.

Petrogress, Inc. (PGAS), closed Monday's trading session at $0.348, up 36.4706%, on 2,051 volume with 4 trades. The average volume for the last 3 months is 10,040 and the stock's 52-week low/high is $0.008999999/$0.0445.

chart

SOL Global Investments Corp. (SOLCF)

Midas Letter, Whale Wisdom, CannabisMarketCap, Financial Buzz, InvestorIntel, MarketWatch, InvestorsHub, YCharts, Marijuana Stock Review, Marketbeat, Investor Ideas, Barchart, Pot Stock News, Market Screener, Business Wire, Investorx, and Stockwatch reported earlier on SOL Global Investments Corp. (SOLCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

SOL Global Investments Corp. is a global investment company listed on the OTC Markets’ OTCQB. The Company centers on, but is not limited to, cannabis and cannabis related companies in legal U.S. States, the hemp and CBD (cannabidiol) marketplaces, and the developing European cannabis and hemp marketplaces. SOL Global Investments has its corporate headquarters in Toronto, Ontario. It also has offices in Fort Lauderdale, Florida, and London, England.

The Company has strategic investments and partnerships across cultivation, distribution and retail. These complement its research and development (R&D) program with the University of Miami. SOL Global is positioning the Company as a future frontrunner in the United States' medical cannabis industry.

SOL’s investments include ECH Ltd.; Verano Holdings LLC; OG DNA Genetics, Inc.; Greenlight Pharmaceuticals Limited; University of Miami; and PRØHBTD Media, Inc. ECH is a group of companies at the vanguard of the European medical cannabis industry. Verano Holdings is a private, vertically integrated, licensed operator of cannabis cultivation, manufacturing and retail facilities across six key U.S. States and Puerto Rico.

OG DNA Genetics is one of the foremost companies in the Cannabis Industry. Greenlight Pharmaceuticals Limited (GreenLight Medicines) is a biopharmaceutical company focused on researching, developing and licensing molecules from proprietary cannabinoid formulations to target a spectrum of disease areas.

Recently, SOL Global Investments announced its intention to spin off its wholly-owned subsidiary, Scythian Biosciences, Inc. (SBI), into an independent, publicly-traded company. Upon closing of the Spin-off, expected to take place on or before September 30, 2019, SOL Global Investments’ shareholders will own shares of both companies. With this Spin-off, SBI will be renamed "Impact Biosciences Corp." It will continue to pursue a drug development in the U.S. for the treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination drug candidate that is undergoing development under contract with the University of Miami.

SOL Global Investments also recently announced the completion of its acquisition of CannCure Investments, Inc. CannCure is a privately-held Ontario corporation that indirectly holds 100 percent of 3 Boys Farms, LLC, a Florida limited liability company with a Florida state license to cultivate, process and dispense medical marijuana.

3 Boys Farms' operations comprise 40,000 square feet of fully-operational greenhouses situated on an eight-acre parcel of land. The existing facilities include a two-acre outdoor mitigation space, which is run 100 percent with harvested rainwater, solar pumps and repurposed high-volume chilled air from the cultivation greenhouses. This results in a zero-carbon footprint. 3 Boys Farms' innovations include alternative energy use, greenhouse cooling designs, and rainwater harvesting. Its innovations were recognized and honored by the Governor's Environmental Leadership Award. Also, 3 Boys Farms has started extraction and processing operations at its new GMP-certified farm and laboratory facility in Indiantown, Florida.

SOL Global Investments Corp. (SOLCF), closed Monday's trading session at $0.31114, up 25.4091%, on 19,837 volume with 30 trades. The average volume for the last 3 months is 44,800 and the stock's 52-week low/high is $0.0003/$0.028999999.

chart

Integrated Ventures, Inc. (INTV)

Promotion Stock Secrets, OTC Markets, Whale Wisdom, The Street, InvestorsHub, Barchart, TradingView, The OTC Reporter, MarketWatch, YCharts, and Investors Hangout reported on Integrated Ventures, Inc. (INTV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Integrated Ventures, Inc. concentrates on operating subsidiaries in the digital currency sector. The Company’s present crypto portfolio includes BitcoLab – cryptocurrency mining and investing. It also includes Nemesis – manufacturing and sales of mining rigs and equipment. The Company previously went by the name EMS Find, Inc. It changed its corporate name to Integrated Ventures, Inc. in July of 2017. Integrated Ventures has its head office in Huntingdon Valley, Pennsylvania.

In addition, Integrated Ventures’ portfolio includes LoanFunder – the financial platform, designed to integrate with a decentralized and encrypted lending ledger. It offers a secure, efficient, verifiable, and permanent way of storing loan related information.

Integrated Ventures has acquired CreditCalc from ITBS, LLC, a high-end loan management and calculation platform. The expectation is that this stock based transaction will expedite the development lifecycle of Integrated Ventures’ blockchain based lending platform - LoanFunder. CreditCalc permits borrowers and lenders to perform complex calculations related to all kinds of loans. Furthermore, CreditCalc provides users access to the custom credit programs and the ability to shop and compare for different kinds of loan products.

Integrated Ventures entered into an Asset Purchase Agreement (APA) with digiMINE, LLC, earlier this year. This APA is to acquire certain cryptocurrency assets, consisting of 150 assorted ASIC miners and related mining equipment and $175,000 in cash, to be used for the purchase of 145 assorted Antminers by Bitmain Technologies. The remaining capital will be used for the build out for the 5,900 sq ft warehouse facility in Marlboro, New Jersey.

Integrated Ventures announced this past May that it executed the APA to acquire the remaining assets of digiMINE consisting of mining rigs, digital currency, and cash. Pursuant to the executed APA, the total consideration for all the assets being acquired comprises 20,000 Restricted Preferred B Shares, to be issued to digiMINE, LLC.

Recently, Integrated Ventures announced that it entered into a Letter Of Intent (LOI) with Secure Hosting, LLC to acquire certain cryptocurrency equipment comprising 199 revenue generating GPU based mining rigs. With this LOI, the aggregate consideration for the Assets being acquired, comprises 39,679 Preferred B restricted shares, being issued to the selling shareholders of the Secure Hosting, LLC.

Integrated Ventures also recently confirmed the signing of a Definitive Asset Purchase Agreement (DAPA) with Secure Hosting to complete the earlier announced acquisition of 182 ETH mining rigs, comprising 114 Fuel 8 GPU RX570; 68 Fuel 8 GPU P102; and 182 Power Source Units.

Integrated Ventures, Inc. (INTV), closed Monday's trading session at $0.017, up 34.9206%, on 3,823,335 volume with 142 trades. The average volume for the last 3 months is 1,270,059 and the stock's 52-week low/high is $0.00095/$0.018999999.

chart

The QualityStocks Company Corner

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (CIIX) was featured today in a publication from CBDWire, examining how, if you’ve been paying the slightest attention to the news lately, you must have heard of cannabidiol oil (CBD). It’s extracted from hemp, a variety of cannabis with less than 0.3% THC (the chemical that creates marijuana’s infamous ‘high’) and it’s said to be a potent natural medicine. Also today, CBDWire featured the company in a report explaining how CIIX is leveraging its tremendous financial expertise to establish itself as a leader in China’s developing cannabidiol (CBD) industry.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Monday's trading session at $0.185, up 20.1299%, on 103,167 volume with 24 trades. The average volume for the last 3 months is 52,429 and the stock's 52-week low/high is $2.28999996/$8.50.

Recent News

chart

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF).

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) was featured today in a publication from HempWireNews, examining how hemp represents a new frontier for American farmers. If things go well, they may be saying goodbye to crops like soybeans and wheat. It has a multitude of applications, and it produces a group of chemicals called cannabinoids that have wide-ranging medicinal properties.

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (OTCQB: HTPRF), closed Monday's trading session at $0.14, even for the day, on 200 volume. The average volume for the last 3 months is 2,901 and the stock's 52-week low/high is $0.451099991/$2.45000004.

Recent News

chart

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF).

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) was featured today in the 420 with CNW by CannabisNewsWire. On Monday, Colorado Governor Jared Polis unveiled a plan through which he seeks to increase the number of financial institutions conducting business with the legal marijuana industry.

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (OTCQB: CANSF), closed Monday's trading session at $0.54675, off by 0.590909%, on 3,339 volume with 7 trades. The average volume for the last 3 months is 10,556 and the stock's 52-week low/high is $0.150000005/$0.51999998.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a publication from Stock Markets Press, examining how CBD consumers are tantalizingly close. More than 40% of consumers aged 21 and above say they would consider trying CBD. The question is: how to close that sale and retain loyal customers for repeat business. The answer is that CBD marketing needs to be sophisticated to achieve effective omni-channel penetration. This is a young but competitive industry with some 70% of all sales coming online.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Monday's trading session at $0.515, up 3.8306%, on 3,933,769 volume with 730 trades. The average volume for the last 3 months is 1,205,406 and the stock's 52-week low/high is $0.100299999/$0.920000016.

Recent News

chart

GP Solutions (OTC: GWPD)

The QualityStocks Daily Newsletter would like to spotlight GP Solutions (GWPD).

GP Solutions (OTC: GWPD), the developer of "GrowPods" – controlled environment automated micro-farms, today announced that it was featured in an iGrow News article that indicates new Controlled Environment Micro-Farms, such as GrowPods, produce food that is "better than organic." According to the publication, huge misconceptions surround organic food. Organic farms can use certain pesticides, despite popular belief, and the labeling of organic food items can cause confusion because some may contain only a percentage of organic ingredients. To view the full press release, visit http://cnw.fm/0rSs2

GP Solutions (OTC: GWPD) is developing scalable farming systems for soil-less indoor organic farming. The company’s GrowPods are automated micro-farms that use hydroponic technology and unique soil systems to cultivate the highest-quality specialty leaf crops. The system is designed and engineered for ease of use, allowing users to farm year-round in any location of the world, supporting the company’s mission to provide customers with the ability to cultivate their own organic “superfoods.”

GrowPod Design & Function

GrowPod is a modular, stackable and mobile vertical growing environment specifically engineered to maximize yield and automation. GrowPods are available as a vertical pod, stacker pod or custom-built pod.

The Stacker Pod is a certified organic soil system that offers growers multiple levels of planting in order to maximize space and produce options with different fruits and vegetables. The Vertical Pod utilizes a vertical hydroponic system. It is affordable, scalable, efficient, automated and sustainable. The output provides customers with fresh and clean produce year-round in any climate. The Custom Pod is built to suit the farmer’s specific crop and grow goals.

Each 320-square-foot GrowPod container will have an annual production capability of up to four times that of outdoor growing methods, dramatically increasing profitability to the grower. The controlled environment of the GrowPod ensures efficient power and water usage in growing a wide range of horticultural and agricultural products in all environments and climates.

Thanks to a combination of hydroponic and certified organic soil systems, crop yields are higher, faster, and more consistent that conventional means. Customers can enjoy an average of eight higher yield crop cycles anywhere in the world.

GrowPod Features:

  • Modular, stackable and mobile
  • Fully insulated, food-grade shipping container
  • Engineered for automation
  • Efficient LED lighting
  • Hydroponic or soil-based platforms
  • Proprietary air and water filtration
  • Climate-controlled
  • Remote monitoring

GP Solutions also offers many services to its customers, including:

  • Shipment and installation service of its shipping container farms
  • On-site training
  • Provision of custom planting and harvesting schedule
  • Provision of growing supplies, seeds, nutrients, packaging, branding and repair materials
  • On-site visits, on-call and scheduled maintenance, and re-supply
  • Remote monitoring and automated control of environmental nutrients, environmental growth factors (PH, temperature, light) and circulation
  • Technical assistance
  • Consulting and custom facility systems design

Competitive Advantage

GrowPods allow cultivation to take place year-round, which maximizes ROI. The systems are sealed from outside pathogens, contaminants, pesticides, and the result is clean and robust crop production.

GP Solutions also has a line of remarkable new proprietary soil mixtures and nutrient lines which contain no animal products. These products are vital, as many other soils and additives can contain harmful pathogens and contaminants that can cause crops to become tainted or fail rigorous testing.

Global Solution

GP Solutions has partnered with the world’s leading food nonprofit companies, including Feeding America, Seeds of Hope, Habitat for Humanity, Meals on Wheels America, L.A. Kitchen, and Farm Bread, to help insecure communities take control of their own food dependence using container farms.

GP Solutions (GWPD), closed Monday's trading session at $0.95, up 55.7377%, on 502 volume with 2 trades. The average volume for the last 3 months is 1,054 and the stock's 52-week low/high is $0.007/$0.023.

Recent News

chart

Endonovo Therapeutics Inc. (ENDV)

The QualityStocks Daily Newsletter would like to spotlight Endonovo Therapeutics Inc. (ENDV).

Endonovo Therapeutics (OTCQB: ENDV) today announced the evaluation of its SofPulse(R) device at major universities for orthopedic surgeries. Endonovo’s FDA-Cleared SofPulse(R) is a non-invasive device utilized for the reduction of postoperative pain and edema and represents a low-cost drug-free solution for reducing opioid usage, accelerating patient recovery and preventing opioid addiction following surgical procedures. To view the full press release, visit http://nnw.fm/ViL41

Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.

In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.

Flagship Therapy

SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s targeted pulsed electromagnetic field (tPEMF) transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone. 

Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.

Certifications

Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.

Management

Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.

Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy. 

Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.

Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.

Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.

David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.

Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.

Steven C. Levin, M.D., Scientific Advisory Board Member
Dr. Steven C. Levin is the regional medical director at Johns Hopkins School of Medicine and medical director at Howard County General Hospital in Columbia, Maryland. Additionally, he is an assistant professor at Johns Hopkins School of Medicine, Department of Anesthesiology. Dr. Levin is currently the co-chair of the Opioid Stewardship Clinical Community as well as a clinical design team leader of the Musculoskeletal Center in the Johns Hopkins Health System. Additionally, Dr. Levin has previously served on the medical school facility at Yale University and at University of Pittsburgh Medical Center. Dr. Levin received his undergraduate degree from University of Pennsylvania and medical degree at the University of Pittsburgh. He completed his residency and fellowship at the University of Pittsburgh Medical Center. His membership in professional and scientific societies has included the American Society of Anesthesiology, American Pain Society, American Society of Regional Anesthesia, Society in Anesthesia and International Association for the Study of Pain.

Peter Novak, M.D., Ph.D., Scientific Advisory Board Member
Dr. Peter Novak is the director of the Autonomic Laboratory at the Department of Neurology, Brigham and Women’s Hospital in Boston, Massachusetts. He is a board-certified neurologist and a board-certified autonomic specialist. He is a member of the American Academy of Neurology, American Autonomic Society and the Autonomic Board of United Council for Neurologic Subspecialties. Dr. Novak graduated from medical school in Bratislava, Slovakia, and completed his neurology residency at Ohio State University. He also completed postdoctoral studies focusing on cardiovascular and autonomic research at Charles University (Prague) the University of Montreal, McGill University (Montreal) and the Mayo Clinic. He has special interests in autoimmune, small fiber and autonomic neuropathies, autoimmune, postural orthostatic tachycardia syndrome and multiple system atrophy. He has written over 70 papers and presented at numerous conferences.

Geoffrey Abrams, M.D., Scientific Advisory Board Member
Dr. Geoffrey Abrams is an assistant professor of orthopedic surgery at the Stanford University School of Medicine and the director of sports medicine for Stanford’s varsity athletes. He specializes in orthopedic sports medicine and arthroscopy of the shoulder, knee and elbow as well as upper extremity joint replacement surgery. Dr. Abrams is a member of the American Academy of Orthopedic Surgeons (AAOS) and the American Orthopedic Society for Sports Medicine (AOSSM), among others, and currently serves as assistant team physician for the NFL’s San Francisco 49ers as well as head team physician for a number of Stanford University varsity athletic teams. He is actively involved in research focusing on the role of inflammatory mediators, and microRNA in particular, on cartilage and tendon damage. Dr. Abrams received his undergraduate degree from Stanford University and his doctorate of medicine from the University of California – San Diego. He completed his residency in orthopedic surgery at Stanford University and went on to receive additional training in Orthopedic Sports Medicine and Shoulder Surgery at Rush University Medical Center in Chicago, Illinois. Dr. Abrams has authored or co-authored over 60 peer-reviewed scientific articles, over 20 book chapters, has presented original research at numerous national and international scientific meetings, and serves as a reviewer for numerous sports medicine scientific journals.

Dr. William Li, Scientific Advisory Board Member
Dr. William Li is CEO and co-founder of the Angiogenesis Foundation. He trained in the lab of Dr. Judah Folkman, pioneer of the angiogenesis field, and has been actively engaged in angiogenesis research and clinical development for 30 years. Under Dr. Li’s leadership, the foundation has developed a unique social enterprise model based on value-creating collaborations with leading biopharmaceutical and medical device companies. Dr. Li is actively engaged in identifying unmet needs in the healthcare space for which clinical and cost-effective technology can offer beneficial solutions. He is a graduate of Harvard, and completed his medical residency training at Massachusetts General Hospital in Boston. He serves as advisor and consultant to leading global public and private companies.

Mykol Larvie, Scientific Advisory Board Member
Recipient of three Harvard Medical Student Teaching awards in Principal Clinic Experience, Mykol Larvie is currently a radiologist in the Cleveland Clinic’s Divisions of Nuclear Medicine and Neuroradiology as well as the director of Functional and Molecular Neuroimaging. With a completed internship in the Department of Medicine as well residency in the Department of Radiology and fellowship in the Division of Neuroradiology at the Massachusetts General Hospital, Dr. Larvie specializes in PET examinations of the brain performed typically for the evaluation of neurodegenerative disease, seizure and tumor. He delivers didactic lectures and case conferences to residents and fellows six times per year and serves as a mentor and advisor to medical students, residents and fellows.

Nathan L. Guerette, Scientific Advisory Board Member
Nathan L. Guerette is the director and president of the Female Pelvic Medicine Institute of Virginia; an associate clinical professor in the division of Urogynecology and Pelvic Reconstructive Surgery at the Medical College of Virginia; a full clinical professor in Urogynecology and Pelvic Reconstructive Surgery at the Riverside Regional Medical Center; and the Robotic Surgery director at the Chippenham and Johnston Willis Medical Center. With a completed fellowship in urogynecology and pelvic reconstructive surgery at the Cleveland Clinic Foundation, Dr. Guerette has won seven awards in the medical and humanitarian departments. He has made nine media appearances, some of which were on PBS and NBC News. He has three board certifications and has ran a surgical mission trip to Trujillo, Peru, through Bon Secours.

Dr. Ashling O’Connor, Scientific Advisory Board Member
Currently a surgeon at the Comprehensive Breast Health Center of the Lahey Medical Center, Dr. O’Connor has won seven awards in the surgical department. She has completed a surgical internship at the Mater Misericordiae Hospital in Dublin as well as a breast surgery fellowship at the University of Massachusetts Interdisciplinary Breast Fellowship. She mentors medical students and surgical residents both in the operating room and in a clinical setting and enjoys biking and triathlons as well as trail and marathon running. She is certified in the Hidden Scar technique in breast surgery as well as in the advanced cardiac life support and is a member of the Protocol Review Committee Umass Memorial Medical Center, the New England Surgical Society and the American College of Surgeons.

Samir Awad, Scientific Advisory Board Member
Samir Awad has worked for the Department of Veterans Affairs since 2000. He has served as the operative care line associate executive, chief of general surgery, and medical director of the Surgical Intensive Care Unit at the MEDVAMC. Dr. Awad’s areas of specialty include liver, pancreas, and acute care surgery, as well as minimally invasive surgical procedures. He is a member of the Association for Academic Surgeons, the Society of University Surgeons, the American College of Surgeons, the Surgical Infection Society, and the Society for Critical Care Medicine. Dr. Awad has authored more than 100 peer-reviewed and invited publications and is the recipient of numerous awards for surgical and research achievements. Dr. Awad is certified by the American Board of Surgery and Surgical Critical Care.

Endonovo Therapeutics Inc. (ENDV), closed Monday's trading session at $1.15, off by 17.2662%, on 219,922 volume with 307 trades. The average volume for the last 3 months is 25,843 and the stock's 52-week low/high is $0.839999973/$6.00810003.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was highlighted today in a publication from Stock Markets Press, examining how, as the CBD pet market skyrockets to $1.7 billion by 2023, as projected by Brightfield Group, CBD companies that focus on this market are seeing opportunities selling to owners of pets, such as horses, cats and dogs.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Monday's trading session at $0.3042, off by 11.6981%, on 703,990 volume with 343 trades. The average volume for the last 3 months is 488,645 and the stock's 52-week low/high is $0.391999989/$0.936500012.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood Holdings (OTCQB: NGTF), the award-winning ice cream company addressing America’s $50 billion-dollar nighttime snacking problem, today announced that pregnancy care providers have begun recommending Nightfood to their pregnant clients, and the Company intends to aggressively pursue and serve this valuable market segment. To view the full press release, visit http://nnw.fm/u7Q7f. Also today, NetworkNewsWire released a report on the company detailing how the award-winning ice cream company, which is addressing America’s $50 billion nighttime snacking problem, is partnering with News America Marketing to kick off its first-ever in-store promotional activities (http://nnw.fm/4SirQ ).

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving late-night snacking for consumers and solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in the ice cream category in a Kantar survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try.

Nightfood has secured distribution in several major regional supermarket chains and has landed media coverage in major outlets such as The Today Show, The Wall Street Journal, Oprah Magazine, USA Today, The Washington Post, Parents Magazine, and many more.

Over 80% of consumers snack regularly at night, and the most popular choices are cookies, chips, candy, and, of course, ice cream. These are understood to be both unhealthy and sleep-disruptive.

Research indicates that human biological programming combined with the trappings of modern life combine to drive this unhealthy behavior pattern. Every week, hundreds of millions of Americans combine to spend an estimated $1B on snacks consumed between dinner and bed.

In a recent Harris Poll online study, 54% of consumers who snack at night reported often feeling guilty about their nighttime snack choices. 58% said they wish they felt more in control of their nighttime snacking.

Nightfood management believes that the company that solves this massive consumer problem can become a national brand with a billion-dollar valuation.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company is seeking licensing opportunities to market such products under the brand name “Half-Baked,” for which they’ve successfully secured trademark rights.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former vice president of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Christensen led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small-cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed Monday's trading session at $0.29, off by 0.240798%, on 372,610 volume with 124 trades. The average volume for the last 3 months is 111,355 and the stock's 52-week low/high is $0.090000003/$3.00.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) announced today that it will report results and host a conference call with Company management for the second quarter fiscal 2020 ending December 28, 2019 at 5:00 PM ET on Monday, February 24, 2020. Conference Call Information. Conference ID: 03558055. Local Toronto Dial-in Number: (+1) 416 764 8609. Local Vancouver Dial-in Number: (+1) 778 383 7417. North American Toll-Free Number:(+1) 888 390 0605. Or access via webcast. The call and replay archive will be accessible on Green Growth Brands' Investor Relations website.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Monday's trading session at $0.2195, off by 14.1639%, on 838,587 volume with 382 trades. The average volume for the last 3 months is 357,191 and the stock's 52-week low/high is $0.007699999/$0.048799999.

Recent News

chart

CloudCommerce (OTCQB: CLWD)

The QualityStocks Daily Newsletter would like to spotlight CloudCommerce (OTCQB: CLWD).

CloudCommerce (OTCQB: CLWD) is a leading provider of audience-driven business intelligence and marketing solutions. Together with its wholly owned subsidiaries, CloudCommerce delivers invaluable end-to-end business intelligence and marketing solutions through a range of services and capabilities.

Flagship Solution

SWARM is an end-to-end solution that applies advanced data science, behavioral science, artificial intelligence and market research techniques to deliver powerful audience-driven business intelligence that converts opportunities into business success.

Through marketing, brand perception, customer-relationship management, human-resources management and operational logistics applications, CloudCommerce’s SWARM solution helps businesses determine who to talk to, what to say and how to motivate targeted audiences to take meaningful action.

The Market

Marketers have largely taken a blanket approach to communication. The same messages are often sent across an entire customer audience with little regard for how different groups of people communicate, build communities and develop their purchasing habits. When marketers do segment audiences, they use objective selection criteria such as income, geography, education or purchase history to deduce attitudes or intentions.

However, research shows that motivations and feelings are much more accurate at predicting behavior. The challenge for businesses is that these factors are also the hardest to gather from audience data. CloudCommerce provides that audience-intelligent data through SWARM, its proprietary behavioral-science approach to audience creation and communication. Through SWARM, CloudCommerce helps marketers identify consumer motivations and triggers in order to effectively predict and influence actions. When companies influence action, they can change opinions, gather support, motivate purchases and inspire change.

In a fast-developing global business intelligence market estimated to grow from $16.3 billion in 2016 to $34.3 billion by 2022, CloudCommerce stands apart as an innovator and true partner, able to deliver data-driven intelligence and solutions that enable its customers to strengthen their brands, deliver their messages and reach their goals.

SWARM Products

THE SWARM—Intelligent Audience Building
The core of the CloudCommerce solution – and what separates CloudCommerce from other audience data companies – is the company’s unique approach to audience building. The concept of “personas” has been around for decades, but CloudCommerce takes that concept to the next level. The SWARM was developed to identify not only who to talk to but also what to say in order to motivate target audiences to take meaningful action. Using CloudCommerce’s proprietary clustering and behavioral analysis techniques, businesses can identify target audiences and deliver messages that are more focused and efficient. CloudCommerce not only helps its client partners find the right people to talk to but also identifies the most powerful message to send.

BUZZ—Behavior-Based Market Research
Market research is evolving. Research techniques developed and used today are more sophisticated and backed by strong data science. Despite these changes, many traditional research firms have failed to innovate: small sample sizes, survey design bias, improper weighting and gut-intuition sampling are just some of the issues that plague the market-research industry. Through BUZZ, CloudCommerce has automated the market research process to provide a level of statistical depth beyond what traditional firms can offer. BUZZ offers businesses the ability to put their finger on the pulse of the marketplace in the moment. Using a wide range of internal and external data sources such as customer data, social media activity, and micro and macro trends, BUZZ deduces attitudes, emotions and opinions.

HIVE—Redefined Geographic Targeting
Conventional geographic audience targeting is outdated. Arbitrary units of location such as counties, cities, DMAs and regions were created centuries ago based on land-rights ownership. Their use in understanding people’s behavior, purchase habits and underlying values is minimal. CloudCommerce has found a much more powerful, efficient and effective way of targeting by clustering people into granular geographic tribes called HIVES. HIVES are defined by attributes such as common language (e.g., colloquialisms), shared experience and narratives (e.g., climate, history), and concentrated demography and biology (e.g., ethnicity, age). Based on the needs of its clients, CloudCommerce can completely redraw the geographic lines based on various Hive selection criteria. Using this exclusive HIVE approach, CloudCommerce clients experience more efficient and effective marketing, make more intelligent business decisions and enjoy more growth.

HONEY—Advanced Reporting and Visualization
Advanced-audience, data-analysis technologies are useless if they don’t produce simple, powerful and actionable business intelligence. HONEY comes with user-friendly reporting and visualization tools to organize and explain all of the advance-data science into a simple-to-understand format for decision makers. HONEY combines the intelligence of client CRM data with third-party consumer data and targeted market research to create a powerful foundation for any audience-intelligence solution.

Subsidiaries

Data Propria
Data Propria delivers the highest Return on Investment (“ROI”) for their customers’ digital marketing campaigns, by utilizing sophisticated data science to identify the correct universes to target relevant audiences. Their ability to understand and translate data drives every decision they make. By listening to and analyzing their customers’ data they are able to make informed decisions that positively impact their customers’ business. Data Propria leverages industry-best tools to aggregate and visualize data across multiple sources, and then their data and behavioral scientists segment and model that data to be deployed in targeted marketing campaigns. They have data analytics expertise in retail, wholesale, distribution, logistics, manufacturing, political, and several other industries.

Parscale Digital
Parscale Digital helps their customers get their message out, educate their market and tell their story. They do so creatively and effectively by deploying powerful call-to-action digital campaigns with national reach and boosting exposure and validation with coordinated advertising in print media. Parscale Digital’s fully-developed marketing plans are founded on sound research methodologies, brand audits and exploration of the competitive landscape. Whether their customer is a challenger brand, a political candidate, or a well-known household name, Parscale Digital’s strategists are skilled at leveraging data and creating campaigns that move people to make decisions.

Giles Design Bureau
Giles Design Bureau approaches branding from a “big picture” perspective, establishing a strong identity and then building on that to develop a comprehensive branding program that tells the customer’s story, and articulates what sets the customer apart from their competitors and establishes the customer in their market.

WebTegrity
WebTegrity develops commerce-focused, user-friendly digital websites and apps that elevate their customer’s marketing position and draw consumers to their products and services. Their platform-agnostic approach allows WebTegrity to architect and build solutions that are the best fit for each customer. Once the digital properties are built, their experts will help manage and protect the website or app and provide the expertise needed to scale the infrastructure needed as the customer’s business grows.

Leadership

Andrew Van Noy, CEO & Chairman of CloudCommerce Board of Directors
Andrew Van Noy has been a director of CloudCommerce since November 2012, president of the company since April 2012, and the CEO of the company since August 2012. He also served as executive vice president of CloudCommerce from November 2011 to April 2012 and vice president of Sales and Marketing of the company from May 2011 to November 2011. From January 2009 to April 2011, Van Noy served as the vice president of Sales and Marketing for PageTransformer, which provided web and software development for iPad, iPhone and Android devices. Van Noy came to CloudCommerce with experience in digital marketing, private equity and investment banking. During his years at the company, Van Noy led the efforts to rebrand and restructure the business and presided over the acquisition of a number of companies. Van Noy graduated from BYU with a Bachelor of Science degree.

Gregory Boden, CFO and Board of Directors
Gregory Boden became a director at CloudCommerce in November 2011 and in February 2013 was named corporate secretary. In April 2012, Boden was also appointed CFO. In addition, Boden is the managing partner of a private equity company. Prior to joining the CloudCommerce team, Boden managed the franchise accounting and cash application departments of Select Staffing, a nationwide staffing company and was an accountant at KPMG LLP. Boden earned his master of accountancy degree from the University of Denver.

CloudCommerce (OTCQB: CLWD), closed Monday's trading session at $0.0033, up 3.125%, on 11,454,659 volume with 134 trades. The average volume for the last 3 months is 23,530,144 and the stock's 52-week low/high is $0.198500007/$0.446249991.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Monday's trading session at $2.71, up 12.4481%, on 167,794 volume with 726 trades. The average volume for the last 3 months is 129,613 and the stock's 52-week low/high is $0.231000006/$2.25999999.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Monday's trading session at $0.093, up 9.4118%, on 16,400 volume with 5 trades. The average volume for the last 3 months is 36,944 and the stock's 52-week low/high is $0.779999971/$3.99.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Monday's trading session at $1.24, up 5.0847%, on 1,194,973 volume with 3,086 trades. The average volume for the last 3 months is 3,598,021 and the stock's 52-week low/high is $0.346799999/$1.75.

Recent News

chart

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)

The QualityStocks Daily Newsletter would like to spotlight Blue Hat Interactive Entertainment Technology (BHAT).

Blue Hat Interactive Entertainment Technology (BHAT) is a cutting-edge creator, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. Blue Hat’s mobile-connected entertainment platform connects physical items to mobile devices through wireless technologies, creating a unique interactive user experience in various mobile games, interactive educational materials and toys with mobile game features.

Blue Hat designs original toys and games that utilize augmented reality technology, motion capture technology, image recognition technology, voice control, light sense technology, infrared, levitation induction, and other trending scientific technologies to transverse the virtual with reality. Blue Hat creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. This combination provides users with a more natural form of human computer interaction, enhances a user’s perception of reality, and delivers a more immersive entertainment experience.

Proprietary Technology

Founded in 2010, Blue Hat’s proprietary technology, product research and development, marketing channels and brand operation are the cornerstones of the business. Blue Hat focuses on the combination of “online” and “offline” activity and the interaction between “entertainment” and “product” to create a high-tech entertainment platform combining mobile games and AR. With the help of computer graphics, motion capture technology, image recognition technology and visualization technologies, Blue Hat accurately “places” virtual objects into the physical world, creating a new and stimulating visual environment for users.

Blue Hat recently displayed a variety of its sci-tech products at the Guangzhou International Toy Exhibition in China including AR Racer, Elastic Bubbles, AR Space Track, AR Alloy Toy Car, AR Need a Spanking, 5D Animated Magic Aquarium, Bug Travelers, AR Picture Book and other interactive games and smart toys.

The company has multiple products in development including new generations of four primary product lines and two new product lines.

Patents and Copyrights

Blue Hat’s advanced AR technology in interactive entertainment is protected by 178 authorized patents with 44 patents in various stages of the application process.

Another 14 applications for Patent Cooperation Treaty, or PCT, have been filed for international patents. As of March 31, 2019, the company owns 645 copyrights for artwork, 71 registered trademarks and 27 software copyrights.

Sales and Marketing

There has been rapid growth in the toys and games industry in China over the last several years. Total retail sales of toys and games in China soared from RMB 111.8 billion in 2012 to RMB 276.5 billion in 2017 with an average annual growth rate of 19.9% in 2017. Blue Hat believes the company is well positioned with little competition as the toy industry rapidly shifts toward intelligent and interactive toys and games. Retail sales of electronic toys grew at 24% annually in 2017 while that of traditional toys grew at 7%.

In addition to a powerful ecommerce presence, Blue Hat has long-term relationships with partnered distributors that place the company’s AR interactive entertainment products into well-known international retail chains and retail outlets. Blue Hat’s integrated online and offline sales channels include e-commerce giants such as Amazon and Alibaba, retail chain stores and the company’s physical experience store located in Xiamen, China. Blue Hat plans to open or franchise approximately 100 additional stores in China by 2021.

Blue Hat’s community-based platform offers users a highly engaged and interactive community with online communication forums and offline social activities. The company advocates a new model of “teaching through lively activities” and combines AR technology with education, integrating its products into situational teaching, roleplaying and man-machine interaction. This novel educational experience helps realize optimal transformation of information, creating a knowledge and enhancing cognition.

Management

Director and CEO Xiaodong (Sean) Chen has over 20 years of experience creating, developing and producing toys and games related products. Chen earned his EMBA from Renmin University of China and has been chairman of the board of directors and general manager of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

CFO and Director Caifan, who has over 20 years of financial accounting and taxation experience, earned a degree in finance from Hunan University of Finance and Economics. He has served as director, deputy general manager and financial controller of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

Jianyong Cai, chief technology officer and director, has over 35 years of experience in data communication principles, communication network foundation, software engineering, communication network theory and technology and computer network architecture. He holds degrees in data communication principles, communication network foundation and software engineering from University of Science and Technology of China. He has been director, deputy general manager and chief engineer of Fujian Blue Hat Interactive Entertainment Technology Ltd. since January 2010.

Blue Hat Interactive Entertainment Technology (BHAT), closed Monday's trading session at $1.28, up 4.065%, on 66,999 volume with 208 trades. The average volume for the last 3 months is 78,570 and the stock's 52-week low/high is $0.023/$1.13999998.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.